ULTRASOUND-GUIDED PERCUTANEOUS PANCREATIC BIOPSY: DIAGNOSTIC PERFORMANCE AND CLINICAL SAFETY

Ngọc Cương Nguyễn, Huy Hoàng Đỗ

Main Article Content

Abstract

Objective: To evaluate the imaging characteristics, histopathological outcomes, and safety of percutaneous ultrasound-guided pancreatic biopsy. Materials and Methods: This prospective descriptive study was conducted on 33 patients with pancreatic lesions who underwent ultrasound-guided percutaneous biopsy at a central hospital from January 2023 to June 2024. Clinical, imaging, histological data, and procedure-related complications were collected and analyzed. Results: The majority of patients were male (60.6%) with a mean age of 63.6 ± 11.2 years. Most pancreatic lesions were located in the head of the pancreas (51.5%), appeared hypoechoic (81.8%), and had irregular margins (75.8%). Adenocarcinoma accounted for 72.7% of histological diagnoses. The sensitivity, specificity, and overall diagnostic accuracy of the procedure were 92.3%, 100%, and 93.9%, respectively. Minor complications occurred in 6.1% of cases and required no specific treatment. Conclusion: Percutaneous ultrasound-guided pancreatic biopsy is a feasible and accurate method with an acceptable safety profile. It can be considered a practical alternative for tissue diagnosis in pancreatic lesions, especially in settings where endoscopic ultrasound is not readily available.

Article Details

References

1. R. L. Siegel, K. D. Miller, N. S. Wagle, and A. Jemal, “Cancer statistics, 2023,” CA. Cancer J. Clin., vol. 73, no. 1, pp. 17–48, Jan. 2023, doi: 10.3322/caac.21763.
2. M. Polkowski et al., “Technical aspects of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline - March 2017,” Endoscopy, vol. 49, no. 10, pp. 989–1006, Oct. 2017, doi: 10.1055/s-0043-119219.
3. M. J. Hewitt, M. J. W. McPhail, L. Possamai, A. Dhar, P. Vlavianos, and K. J. Monahan, “EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis,” Gastrointest. Endosc., vol. 75, no. 2, pp. 319–331, Feb. 2012, doi: 10.1016/j.gie.2011.08.049.
4. S. Gupta et al., “Quality improvement guidelines for percutaneous needle biopsy,” J. Vasc. Interv. Radiol. JVIR, vol. 21, no. 7, pp. 969–975, Jul. 2010, doi: 10.1016/j.jvir.2010.01.011.
5. S. Iodice, S. Gandini, P. Maisonneuve, and A. B. Lowenfels, “Tobacco and the risk of pancreatic cancer: a review and meta-analysis,” Langenbecks Arch. Surg., vol. 393, no. 4, pp. 535–545, Jul. 2008, doi: 10.1007/s00423-007-0266-2.
6. “Cancer Facts & Figures 2023 | American Cancer Society.” Accessed: Jul. 24, 2025. [Online]. Available: https://www.cancer.org/ research/cancer-facts-statistics/all-cancer-facts-figures/2023-cancer-facts-figures.html
7. “704-viet-nam-fact-sheet.pdf.” Accessed: Jul. 24, 2025. [Online]. Available: https://gco.iarc. who.int/media/globocan/factsheets/populations/704-viet-nam-fact-sheet.pdf
8. “Contrast‐enhanced ultrasound of pancreatic tumours - De Robertis - 2014 - Australasian Journal of Ultrasound in Medicine - Wiley Online Library.” Accessed: Jul. 24, 2025. [Online]. Available: https://onlinelibrary.wiley.com/doi/full/10.1002/j.2205-0140.2014.tb00032.x
9. C. W. Teshima and G. S. Sandha, “Endoscopic ultrasound in the diagnosis and treatment of pancreatic disease,” World J. Gastroenterol. WJG, vol. 20, no. 29, pp. 9976–9989, Aug. 2014, doi: 10.3748/wjg.v20.i29.9976.
10. “EUS-guided fine needle biopsy of pancreatic masses can yield true histology - PubMed.” Accessed: Jul. 24, 2025. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/ 28988195/